Pharmacokinetic studies of a new substance of the water-soluble sulfur-containing antioxidant рotassium 3-(4-hydroxy-3,5-dimethylbenzylthio)propionate (TF-7)

Introduction. Pharmacokinetic (screening) studies are particularly relevant for the development of new substances and drugs. These studies investigate the basic processes such as absorption, distribution, metabolism and elimination (ADME) of a pharmaceutical substance. Pharmacokinetic parameters are of key importance to clinicians, as they provide data necessary for determining optimal dosages.

Aim. To study the pharmacokinetic characteristics of a new substance of the water-soluble sulfur-containing antioxidant potassium 3-(4-hydroxy-3,5-dimethylbenzylthio) propionate (TF-7).

Material s and methods . A TF-7 solution was administered to rats intragastrically at a dose of 500 mg/kg. Blood samples were collected 1,5, 3, 5, 8, and 12 h after administration of the substance. The TF-7 concentration was measured using stripping voltammetry. Calculations of pharmacokinetic parameters were performed using the single-compartment pharmacokinetic model – by the classical method according to Kholodov and using the Borgia 1.03 program.

Results . The main pharmacokinetic parameters of the new TF-7 substance were calculated including half-life (t_1/2), elimination rate constant (k_el), total clearance (Cl_t), effective concentration (C_eff ), and volume of distribution (V_d).

Conclusion. The study showed rapid (t_1/2) and effective distribution (C_eff , V_d) of TF-7 in the body, which ensures its ability to interact with all cellular and tissue structures. The half-life of TF-7 ranges from 1 to 1,5 h, indicating both a rapid onset of pharmacological effect and quite rapid elimination from the body.

1. Bhatt S., Puli L., Patil C.R. Role of reactive oxygen species in the progression of Alzheimer’s disease // Drug Discov. Today. 2021;26(3):794-803. DOI: 10.1016/j.drudis.2020.12.004.

2. Xu X., Liu A., Hu S. et al. Synthetic phenolic antioxidants: Metabolism, hazards and mechanism of action // Food Chemistry. 2021;353:129488. DOI: 10.1016/j.foodchem.2021.129488.

3. Barteková M., Adameová A., Görbe A. et al. Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases // Free Radic. Biol. Med. 2021;169:446-477. DOI: 10.1016/j.freeradbiomed.2021.03.045.

4. Трегубова И.А., Косолапов В.А., Спасов А.А. Антиоксиданты: современное состояние и перспективы // Успехи физиологических наук. 2012;43(1):75-94.

5. Neha K., Haider M., Pathak A., Yar M.S. Medicinal prospects of antioxidants: A review // Eur. J. Med. Chem. 2019;178:687-704. DOI: 10.1016/j.ejmech.2019.06.010.

6. Белоусов Ю.Б., Гуревич К.Г. Клиническая фармакокинетика. Практика дозирования лекарств. М., 2005. 288 с.

7. Холодов Л.Е., Яковлев В.П. Клиническая фармакокинетика. М., 1985. 464 с.

8. Siraj K., Rehman M.U., Khan M.Z.I. et al. In vitro and in vivo antioxidant therapeutic evaluation of phytochemicals from diff erent parts of Dodonaea viscosa Jacq // Front. Chem. 2023;1:1268949. DOI: 10.3389/fchem.2023.1268949.

9. Чернышева Г.А., Гурто Р.В., Хазанов В.А. и др. Фармакокинетика тиофана при внутрижелудочном введении // Химико-фармацевтический журнал. 2010;44(4):7-10. DOI: 10.30906/0023-1134-2010-44-4-7-10.

10. Мукундви В.T., Ивановская Е.А., Лигостаев А.В. Разработка методики количественного определения субстанции гидрофильного антиоксиданта TФ-7 методом инверсионной вольтамперометрии // Journal of Siberian Medical Sciences. 2024;8(2):80-89. DOI: 10.31549/2542-1174-2024-8-2-80-89.

11. Справочник биохимика / Р. Досон, Д. Эллиот, У. Эллиот, К. Джонс; пер. с англ. В.Л. Друцы, О.Н. Королевой. М.: Мир, 1991. С. 481.